Compliance

Fusion Fuel Green PLC Announces 1-for-35 Reverse Share Split to Regain Nasdaq Compliance

Fusion Fuel Green PLC Announces 1-for-35 Reverse Share Split to Regain Nasdaq Compliance

Fusion Fuel Green PLC's reverse share split aims to meet Nasdaq's minimum bid price requirement, impacting shareholders and the company's market position.

July 10, 2025
Punyam Academy Introduces ISO 37001:2025 Lead Auditor E-Learning Course

Punyam Academy Introduces ISO 37001:2025 Lead Auditor E-Learning Course

Punyam Academy's new online course offers comprehensive training on the latest anti-bribery management systems standard, making auditor training accessible globally.

June 25, 2025
GlobalManagerGroup.com Unveils ISO 37001:2025 Documentation Kit for Anti-Bribery Management

GlobalManagerGroup.com Unveils ISO 37001:2025 Documentation Kit for Anti-Bribery Management

GlobalManagerGroup.com has launched an updated ISO 37001:2025 Documentation Kit, designed to help organizations implement an effective Anti-Bribery Management System, aligning with the latest standards to combat bribery risks.

June 16, 2025
Fusion Fuel Green PLC Proposes Reverse Share Split to Meet Nasdaq Compliance

Fusion Fuel Green PLC Proposes Reverse Share Split to Meet Nasdaq Compliance

Fusion Fuel Green PLC announces its Annual General Meeting on June 25, 2025, featuring a vote on a reverse share split aimed at regaining Nasdaq compliance, highlighting the company's strategic moves towards sustainability and growth.

June 4, 2025
Crypto Tax Compliance: Expert Warns of Increasing IRS Scrutiny

Crypto Tax Compliance: Expert Warns of Increasing IRS Scrutiny

A recent interview with crypto tax attorney Andrew Gordon reveals critical insights into digital asset taxation, highlighting the importance of proper record-keeping and proactive compliance as IRS enforcement intensifies.

May 12, 2025
TransCode Therapeutics Implements 1-for-28 Reverse Stock Split to Maintain Nasdaq Compliance

TransCode Therapeutics Implements 1-for-28 Reverse Stock Split to Maintain Nasdaq Compliance

TransCode Therapeutics will execute a reverse stock split to increase its per-share price and meet Nasdaq listing requirements, reducing outstanding shares from 23.3 million to approximately 833,620.

May 6, 2025
CyberloQ Technologies Achieves SOC 2 Compliance and Files Second Patent, Positioning for Market Expansion

CyberloQ Technologies Achieves SOC 2 Compliance and Files Second Patent, Positioning for Market Expansion

CyberloQ Technologies has secured SOC 2 Type 1 compliance and filed a second patent, signaling strategic moves to enter banking and fintech markets with enhanced multi-factor authentication solutions. These milestones represent a critical transition for the company toward revenue generation and market differentiation.

April 29, 2025
PreviousPage 2 of 2Next